Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Fenoglio, D. Galimberti, L. Piccio, D. Scalabrini, P. Panina, C. Buonsanti, E. Venturelli, C. Lovati, G. Forloni, C. Mariani, N. Bresolin, E. Scarpini (2007)
Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar DegenerationNeuroscience Letters, 411
R. Guerreiro, Aleksandra Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie, Carlos Cruchaga, C. Sassi, J. Kauwe, S. Younkin, L. Hazrati, J. Collinge, J. Pocock, T. Lashley, Julie Williams, J. Lambert, P. Amouyel, A. Goate, R. Rademakers, K. Morgan, J. Powell, P. George-Hyslop, A. Singleton, J. Hardy (2013)
TREM2 variants in Alzheimer's disease.The New England journal of medicine, 368 2
R. Ferrari, M. Grassi, E. Salvi, B. Borroni, Fernando Palluzzi, D. Pepe, Francesca D’Avila, A. Padovani, S. Archetti, I. Rainero, E. Rubino, L. Pinessi, L. Benussi, G. Binetti, R. Ghidoni, D. Galimberti, E. Scarpini, M. Serpente, G. Rossi, G. Giaccone, F. Tagliavini, B. Nacmias, I. Piaceri, S. Bagnoli, A. Bruni, R. Maletta, L. Bernardi, A. Postiglione, G. Milan, M. Franceschi, A. Puca, V. Novelli, C. Barlassina, N. Glorioso, P. Manunta, A. Singleton, D. Cusi, J. Hardy, P. Momeni (2015)
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementiaNeurobiology of Aging, 36
S. Rayaprolu, B. Mullen, M. Baker, T. Lynch, E. Finger, W. W. Seeley, O. A. Ross (2013)
TREM2 in neurodegeneration: Evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease, 8
Thorlákur Jónsson, H. Stefánsson, S. Steinberg, I. Jónsdóttir, P. Jonsson, J. Snaedal, Sigurbjorn Bjornsson, J. Huttenlocher, A. Levey, J. Lah, D. Rujescu, H. Hampel, I. Giegling, O. Andreassen, K. Engedal, I. Ulstein, S. Djurovic, C. Ibrahim-Verbaas, A. Hofman, M. Ikram, C. Duijn, U. Thorsteinsdóttir, K. Stefánsson (2012)
Variant of TREM 2 Associated with the Risk of Alzheimer ’ s Disease
B. Borroni, F. Ferrari, D. Galimberti, B. Nacmias, C. Barone, S. Bagnoli, C. Fenoglio, I. Piaceri, S. Archetti, C. Bonvicini, M. Gennarelli, M. Turla, E. Scarpini, S. Sorbi, A. Padovani (2014)
Heterozygous TREM2 mutations in frontotemporal dementiaNeurobiology of Aging, 35
C. Lill, A. Rengmark, L. Pihlstrøm, I. Fogh, A. Shatunov, P. Sleiman, Li-San Wang, Tian Liu, C. Lassen, Esther Meissner, Panos Alexopoulos, A. Calvo, A. Chiò, N. Dizdar, F. Faltraco, L. Forsgren, J. Kirchheiner, A. Kurz, J. Larsen, M. Liebsch, J. Linder, K. Morrison, H. Nissbrandt, M. Otto, J. Pahnke, Amanda Partch, G. Restagno, D. Rujescu, C. Schnack, C. Shaw, P. Shaw, H. Tumani, O. Tysnes, O. Valladares, V. Silani, L. Berg, W. Rheenen, J. Veldink, U. Lindenberger, E. Steinhagen-Thiessen, S. Teipel, R. Perneczky, H. Hakonarson, H. Hampel, C. Arnim, J. Olsen, V. Deerlin, A. Al-Chalabi, M. Toft, B. Ritz, L. Bertram (2015)
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's diseaseAlzheimer's & Dementia, 11
R. Guerreiro, Aleksandra Wojtas, J. Bras, M. Carrasquillo, E. Rogaeva, E. Majounie, C. Cruchaga, C. Sassi, S. Younkin, L. Hazrati, J. Collinge, J. Pocock, T. Lashley, J. Williams, J. Lambert, P. Amouyel, A. Goate, R. Rademakers, K. Morgan, J. Powell, A. Singleton, J. Hardy (2012)
TREM2 Variants in Alz hei mer's Disease
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA StatementOpen Medicine, 3
A. Ruiz, O. Dols-Icardo, M. Bullido, P. Pástor, The Consortium (2014)
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementiaNeurobiology of Aging, 35
Thorlákur Jónsson, H. Stefánsson, S. Steinberg, I. Jónsdóttir, Pálmi Jónsson, J. Snaedal, Sigurbjorn Bjornsson, J. Huttenlocher, A. Levey, J. Lah, D. Rujescu, H. Hampel, I. Giegling, O. Andreassen, K. Engedal, I. Ulstein, S. Djurovic, C. Ibrahim-Verbaas, A. Hofman, M. Ikram, C. Duijn, U. Thorsteinsdóttir, A. Kong, K. Stefánsson (2013)
Variant of TREM2 associated with the risk of Alzheimer's disease.The New England journal of medicine, 368 2
A. Lopez‐Caceres, A. Laserna, C. Triviño‐Martínez, E. Garcia‐Cifuentes, J. C. Gómez‐Vega, P. Ayala‐Ramírez, D. Matallana (2016)
TREM2 variant p.His157Tyr in Colombian patients with frontotemporal dementia, 138
R. Rademakers, M. Hutton (2007)
The genetics of frontotemporal lobar degenerationCurrent Neurology and Neuroscience Reports, 7
Cyril Pottier, Thomas Ravenscroft, Monica Sanchez-Contreras, R. Rademakers (2016)
Genetics of FTLD: overview and what else we can expect from genetic studiesJournal of Neurochemistry, 138
C. Slattery, J. Beck, L. Harper, G. Adamson, Z. Abdi, J. Uphill, T. Campbell, R. Druyeh, Colin Mahoney, J. Rohrer, Janna Kenny, J. Lowe, K. Leung, J. Barnes, S. Clegg, M. Blair, Jennifer Nicholas, R. Guerreiro, J. Rowe, Claudia Ponto, I. Zerr, H. Kretzschmar, P. Gambetti, S. Crutch, J. Warren, M. Rossor, N. Fox, J. Collinge, J. Schott, S. Mead (2014)
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementiaAlzheimer's & Dementia, 10
(2016)
Frequency and contribution of variants in 17 dementia related genes in a Bulgarian dementia cohort
Ru-jing Ren, Yue Huang, Gang Xu, Chun-bo Li, Q. Cheng, S. Chen, Gang Wang (2012)
History, Present, and Progress of Frontotemporal Dementia in China: A Systematic ReviewInternational Journal of Alzheimer's Disease, 2012
L. T. Takada (2015)
The genetics of monogenic frontotemporal dementia. [GenÉtica da demÊncia frontotemporal monogÊnica], 9
J. Paloneva, T. Manninen, G. Christman, K. Hovanes, J. Mandelin, R. Adolfsson, M. Bianchin, T. Bird, R. Miranda, A. Salmaggi, L. Tranebjaerg, Y. Konttinen, L. Peltonen (2002)
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.American journal of human genetics, 71 3
E. Chouery, V. Delague, A. Bergougnoux, S. Koussa, J. Serre, A. Mégarbané (2008)
Mutations in TREM2 lead to pure early‐onset dementia without bone cystsHuman Mutation, 29
E. Premi, A. Padovani, B. Borroni (2012)
Frontotemporal Lobar Degeneration.Advances in experimental medicine and biology, 724
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.Physical therapy, 89 9
Elise Cuyvers, K. Bettens, S. Philtjens, T. Langenhove, I. Gijselinck, J. Zee, S. Engelborghs, M. Vandenbulcke, Jasper Dongen, N. Geerts, Githa Maes, Maria Mattheijssens, K. Peeters, P. Cras, R. Vandenberghe, P. Deyn, C. Broeckhoven, M. Cruts, K. Sleegers (2014)
Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementiaNeurobiology of Aging, 35
A. Sieben, T. Langenhove, S. Engelborghs, Jean-Jacques Martin, P. Boon, P. Cras, P. Deyn, P. Santens, C. Broeckhoven, M. Cruts (2012)
The genetics and neuropathology of frontotemporal lobar degenerationActa Neuropathologica, 124
D. Galimberti, E. Scarpini (2012)
Genetics of Frontotemporal Lobar DegenerationFrontiers in Neurology, 3
M. Thelen, C. Razquín, I. Hernández, A. Gorostidi, R. Sánchez-Valle, S. Ortega-Cubero, S. Wolfsgruber, D. Drichel, K. Fliessbach, Tanja Duenkel, M. Damian, S. Heilmann, Anja Slotosch, M. Lennarz, M. Seijo-Martínez, R. Reñé, J. Kornhuber, O. Peters, C. Luckhaus, H. Jahn, M. Hüll, E. Rüther, J. Wiltfang, E. Lorenzo, J. Gascón, A. Lleó, A. Lladó, J. Campdelacreu, F. Moreno, H. Ahmadzadehfar, J. Fortea, B. Indakoetxea, M. Heneka, A. Wetter, M. Pastor, M. Riverol, T. Becker, L. Frölich, L. Tárraga, M. Boada, M. Wagner, F. Jessen, W. Maier, J. Clarimón, A. Munain, A. Ruiz, P. Pástor, A. Ramírez (2014)
Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypesNeurobiology of Aging, 35
J. Diehl-Schmid, M. Neumann, S. Laws, R. Perneczky, T. Grimmer, A. Danek, A. Kurz, M. Riemenschneider, Hans Förstl (2009)
Frontotemporale LobärdegenerationenFortschritte der Neurologie · Psychiatrie, 77
S. Rayaprolu, Bianca Mullen, M. Baker, T. Lynch, E. Finger, W. Seeley, K. Hatanpaa, C. Lomen‐Hoerth, A. Kertesz, E. Bigio, C. Lippa, K. Josephs, D. Knopman, C. White, R. Caselli, I. Mackenzie, B. Miller, M. Boczarska-Jedynak, G. Opala, A. Krygowska-Wajs, M. Barcikowska, S. Younkin, R. Petersen, N. Ertekin-Taner, R. Uitti, J. Meschia, K. Boylan, B. Boeve, N. Graff-Radford, Z. Wszolek, D. Dickson, R. Rademakers, O. Ross (2013)
neurodegeneration : evidence for association of the p . R 47 H variant with frontotemporal dementia and Parkinson ¿ s disease Permalink
Christina Lilla, Aina Rengmarkc, Lasse Pihlstrømc, Isabella Foghd, Aleksey Shatunovd, Patrick Sleimane, Li-San Wangh, Tianning Liui, Christina Lassenj, Esther Meissnerb, Panos Alexopoulosk, Andrea Calvol, Adriano Chiol, Nil Dizdarn, Frank Faltracoo, Lars Forsgrenp, Julia Kirchheinerq, Alexander Kurzk, Jan Larsenr, Maria Liebschb, Jan Linderp, Karen Morrisons, Hans Nissbrandtu, Markus Ottoq, Jens Pahnkev, Amanda Partchh, Gabriella Restagnox, Dan Rujescuy, Cathrin Schnackq, Christopher Shawd, Pamela Shawz, Hayrettin Tumaniq, Ole-Bjørn Tysnesaa, Otto Valladaresh, Vincenzo Silaniac, Leonard Bergae, Wouter Rheenenae, Jan Veldinkae, Ulman Lindenbergeri, Elisabeth Steinhagen-Thiessenaf, Stefan Teipelag, Robert Perneczkyk, Hakon Hakonarsone, Harald Hampelak, Christine Arnimq, Jørgen Olsenj, Vivianna Deerlinh, Ammar Al-Chalabid, Mathias Toftc, Beate Ritzam, Lars Bertrama (2015)
The role of TREM 2 R 47 H as a risk factor for Alzheimer ’ s disease , frontotemporal lobar degeneration , amyotrophic lateral sclerosis , and Parkinson ’ s disease
D. Galimberti, C. Fenoglio, M. Serpente, S. Cioffi, C. Barone, A. Arighi, E. Scarpini (2014)
TREM2 genetic variability in patients with Alzheimer's disease and frontotemporal lobar degeneration, 261
I. Rainero, E. Rubino, A. Michelerio, F. D’Agata, Salvatore Gentile, L. Pinessi (2017)
Recent advances in the molecular genetics of frontotemporal lobar degeneration.Functional neurology, 32 1
S. Lattante, S. Ciura, G. Rouleau, E. Kabashi (2015)
Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD).Trends in genetics : TIG, 31 5
R. Guerreiro, E. Lohmann, J. Bras, J. Gibbs, J. Rohrer, N. Gurunlian, B. Dursun, B. Bilgiç, H. Hanagasi, H. Gurvit, M. Emre, A. Singleton, J. Hardy (2012)
Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.JAMA neurology, 70 1
L. Takada (2015)
The Genetics of Monogenic Frontotemporal DementiaDementia & Neuropsychologia, 9
S. Lattante, I. Ber, A. Camuzat, S. Dayan, C. Godard, Inge Bortel, A. Septenville, S. Ciura, A. Brice, E. Kabashi (2013)
TREM2 mutations are rare in a French cohort of patients with frontotemporal dementiaNeurobiology of Aging, 34
H. Neumann, M. Daly (2013)
Variant TREM2 as risk factor for Alzheimer's disease.The New England journal of medicine, 368 2
Polymorphisms of the triggering receptor expressed on myeloid cells 2 (TREM2) gene have been reported to be potentially associated with the risks of developing frontotemporal lobar degeneration (FTLD), with inconsistent conclusions. This study aims to comprehensively investigate the potential role of TREM2 variants in FTLD risks via a meta‐analysis. We included a total of eight eligible articles. For TREM2 rs75932628, we observed a significantly increased FTLD risk in the models of T vs. C [Association Test, odds ratio (OR) = 2.43, 95% confidence interval (CI) = 1.43∼4.14, P = 0.001], CT vs. CC (OR = 2.27, 95% CI = 1.39∼3.71, P = 0.001), CT + TT vs. CC (OR = 2.27, 95% CI = 1.38∼3.71, P = 0.001), and Carrier T vs. C (OR = 2.26, 95% CI = 1.38∼3.69, P = 0.001). Similarly, we observed positive results for TREM2 rs2234253 in all of the genetic models (all OR > 1, P = 0.030). Nevertheless, we did not observe any statistical difference between the case and control groups in the pooled analyses of TREM2 rs142232675 and rs143332484 (all P > 0.05). Our findings identified the rs75932628 and rs2234253 polymorphisms of the TREM2 gene as risk factors for FTLD in Caucasian populations.
Annals of Human Genetics – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.